Spinal Muscular Atrophy Treatment Market Insights Video

According to Cognitive Market Research, the global Spinal Muscular Atrophy Treatment market size is USD 4518.20 million in 2024. It will expand at a compound annual growth rate (CAGR) of 7.00% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 1807.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1355.46 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1039.19 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2031.
• Latin America had a market share for more than 5% of the global revenue with a market size of USD 225.91 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 90.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.
• The Nusinersen held the highest Spinal Muscular Atrophy Treatment market revenue share in 2024.